{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:53:25Z","timestamp":1794416005395,"version":"4.9.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012645","name":"Kentucky Spinal Cord and Head Injury Research Trust","doi-asserted-by":"publisher","award":["15-14A"],"award-info":[{"award-number":["15-14A"]}],"id":[{"id":"10.13039\/100012645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000117"],"award-info":[{"award-number":["UL1TR000117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31NS086395"],"award-info":[{"award-number":["F31NS086395"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM109098"],"award-info":[{"award-number":["P20 GM109098"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1S10 OD023573-01"],"award-info":[{"award-number":["1S10 OD023573-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM104942"],"award-info":[{"award-number":["U54GM104942"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.expneurol.2020.113243","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T01:57:51Z","timestamp":1581299871000},"page":"113243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Bioenergetic restoration and neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury"],"prefix":"10.1016","volume":"327","author":[{"given":"Heather M.","family":"Yonutas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7018-0148","authenticated-orcid":false,"given":"W. Brad","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh D.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-5235","authenticated-orcid":false,"given":"Hemendra J.","family":"Vekaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner J.","family":"Geldenhuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7418-4760","authenticated-orcid":false,"given":"Patrick G.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2020.113243_bb0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3171\/jns.1997.86.2.0241","article-title":"Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study","volume":"86","author":"Bergsneider","year":"1997","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.expneurol.2020.113243_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2005.06.019","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury","volume":"388","author":"Besson","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2020.113243_bb0015","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jmgm.2011.04.001","article-title":"Novel ligands that target the mitochondrial membrane protein mitoneet","volume":"29","author":"Bieganski","year":"2011","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.expneurol.2020.113243_bb0020","series-title":"Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation","author":"Cdc","year":"2015"},{"key":"10.1016\/j.expneurol.2020.113243_bb0025","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1152\/ajpendo.00424.2003","article-title":"Identification of a novel mitochondrial protein (\u201cmitoneet\u201d) cross-linked specifically by a thiazolidinedione photoprobe","volume":"286","author":"Colca","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2020.113243_bb0030","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/jnr.21628","article-title":"Fasting is neuroprotective following traumatic brain injury","volume":"86","author":"Davis","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2020.113243_bb0035","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1073\/pnas.1303360110","article-title":"Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier","volume":"110","author":"Divakaruni","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2020.113243_bb0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bmcl.2009.12.088","article-title":"Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoneet","volume":"20","author":"Geldenhuys","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2020.113243_bb0045","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.drudis.2014.05.001","article-title":"Mitoneet as a novel drug target for mitochondrial dysfunction","volume":"19","author":"Geldenhuys","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.expneurol.2020.113243_bb0050","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/j.bmcl.2016.09.009","article-title":"Identification of small molecules that bind to the mitochondrial protein mitoneet","volume":"26","author":"Geldenhuys","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2020.113243_bb0055","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/neu.2008.0857","article-title":"Early mitochondrial dysfunction after cortical contusion injury","volume":"26","author":"Gilmer","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0065","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/neu.2014.3482","article-title":"Endogenous nutritive support after traumatic brain injury: peripheral lactate production for glucose supply via gluconeogenesis","volume":"32","author":"Glenn","year":"2015","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuint.2017.03.015","article-title":"Time courses of post-injury mitochondrial oxidative damage and respiratory dysfunction and neuronal cytoskeletal degradation in a rat model of focal traumatic brain injury","volume":"111","author":"Hill","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2020.113243_bb0075","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/jnr.24271","article-title":"Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice","volume":"96","author":"Hubbard","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2020.113243_bb0080","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1089\/neu.2018.5990","article-title":"Acute mitochondrial impairment underlies prolonged cellular dysfunction after repeated mild traumatic brain injuries","volume":"36","author":"Hubbard","year":"2019","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2008.04.025","article-title":"Rosiglitazone, a ppar gamma agonist, attenuates inflammation after surgical brain injury in rodents","volume":"1215","author":"Hyong","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2020.113243_bb0090","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Fsl. Neuroimage"},{"key":"10.1016\/j.expneurol.2020.113243_bb0095","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of ppar-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.expneurol.2020.113243_bb0100","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1089\/neu.2016.4628","article-title":"Synaptic mitochondria sustain more damage than non-synaptic mitochondria after traumatic brain injury and are protected by cyclosporine a","volume":"34","author":"Kulbe","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0105","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/nm.2899","article-title":"Mitoneet-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity","volume":"18","author":"Kusminski","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2020.113243_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00395-015-0471-z","article-title":"Novel thiazolidinedione mitoneet ligand-1 acutely improves cardiac stem cell survival under oxidative stress","volume":"110","author":"Logan","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.expneurol.2020.113243_bb0115","doi-asserted-by":"crossref","first-page":"104611","DOI":"10.1016\/j.nbd.2019.104611","article-title":"Pioglitazone improves working memory performance when administered in chronic tbi","volume":"132","author":"Mcguire","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2020.113243_bb0120","first-page":"87","article-title":"Stress biomarkers in a rat model of decompression sickness","volume":"78","author":"Montcalm-Smith","year":"2007","journal-title":"Aviat. Space Environ. Med."},{"key":"10.1016\/j.expneurol.2020.113243_bb0125","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1089\/neu.2006.0229","article-title":"Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury","volume":"24","author":"Opii","year":"2007","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1089\/neu.2006.3673","article-title":"Post-injury administration of mitochondrial uncouplers increases tissue sparing and improves behavioral outcome following traumatic brain injury in rodents","volume":"24","author":"Pandya","year":"2007","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.expneurol.2009.05.023","article-title":"The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler fccp","volume":"218","author":"Pandya","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113243_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnene.2013.00010","article-title":"Concentration dependent effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters","volume":"5","author":"Pandya","year":"2013","journal-title":"Front. Neuroenerg."},{"key":"10.1016\/j.expneurol.2020.113243_bb0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.expneurol.2014.04.020","article-title":"N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following tbi","volume":"257","author":"Pandya","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113243_bb0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/978-1-4939-3816-2_32","article-title":"Advanced and high-throughput method for mitochondrial bioenergetics evaluation in neurotrauma","volume":"1462","author":"Pandya","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.expneurol.2020.113243_bb0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1523-1755.2002.00476.x","article-title":"Effects of different ppargamma-agonists on mcp-1 expression and monocyte recruitment in experimental glomerulonephritis","volume":"62","author":"Panzer","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.expneurol.2020.113243_bb0160","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1089\/neu.2015.4185","article-title":"Serial diffusion tensor imaging in vivo predicts long-term functional recovery and histopathology in rats following different severities of spinal cord injury","volume":"33","author":"Patel","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2017.03.021","article-title":"Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery","volume":"293","author":"Patel","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113243_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchromb.2013.11.048","article-title":"A quantitative lc-ms\/ms method for determination of thiazolidinedione mitoneet ligand nl-1 in mouse serum suitable for pharmacokinetic studies","volume":"945-946","author":"Pedada","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.expneurol.2020.113243_bb0175","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1194\/jlr.R046706","article-title":"The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury","volume":"55","author":"Prins","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2020.113243_bb0180","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.4103\/1673-5374.219040","article-title":"Targeting mitoneet with pioglitazone for therapeutic neuroprotection after spinal cord injury","volume":"12","author":"Rabchevsky","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2020.113243_bb0185","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1089\/neu.2011.1755","article-title":"Post-injury administration of the mitochondrial permeability transition pore inhibitor, nim811, is neuroprotective and improves cognition after traumatic brain injury in rats","volume":"28","author":"Readnower","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2010.10.003","article-title":"Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury","volume":"227","author":"Sauerbeck","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113243_bb0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jneumeth.2011.03.007","article-title":"Analysis of regional brain mitochondrial bioenergetics and susceptibility to mitochondrial inhibition utilizing a microplate based system","volume":"198","author":"Sauerbeck","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2020.113243_bb0200","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/neu.1999.16.783","article-title":"Cyclosporin a significantly ameliorates cortical damage following experimental traumatic brain injury in rodents","volume":"16","author":"Scheff","year":"1999","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0205","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/febs.13992","article-title":"Pioglitazone inhibits mitochondrial pyruvate metabolism and glucose production in hepatocytes","volume":"284","author":"Shannon","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2020.113243_bb0210","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.jcbfm.9600297","article-title":"Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy","volume":"26","author":"Singh","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2020.113243_bb0215","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1523\/JNEUROSCI.19-15-06248.1999","article-title":"Exacerbation of damage and altered nf-kappab activation in mice lacking tumor necrosis factor receptors after traumatic brain injury","volume":"19","author":"Sullivan","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113243_bb0220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W","article-title":"Dietary supplement creatine protects against traumatic brain injury","volume":"48","author":"Sullivan","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2020.113243_bb0225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/neu.2010.1646","article-title":"Therapeutic window analysis of the neuroprotective effects of cyclosporine a after traumatic brain injury","volume":"28","author":"Sullivan","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0230","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bbamcr.2014.10.014","article-title":"Structure-function analysis of neet proteins uncovers their role as key regulators of iron and ros homeostasis in health and disease","volume":"1853","author":"Tamir","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2020.113243_bb0235","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/neu.2010.1685","article-title":"Pioglitazone reduces secondary brain damage after experimental brain trauma by ppar-gamma-independent mechanisms","volume":"28","author":"Thal","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2020.113243_bb0240","doi-asserted-by":"crossref","first-page":"H1453","DOI":"10.1152\/ajpheart.00554.2015","article-title":"Drug-induced mitochondrial dysfunction and cardiotoxicity","volume":"309","author":"Varga","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.expneurol.2020.113243_bb0245","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1073\/pnas.1706643114","article-title":"Mitoneet-dependent formation of intermitochondrial junctions","volume":"114","author":"Vernay","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2020.113243_bb0250","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1074\/jbc.M117.789800","article-title":"The mitochondrial outer membrane protein mitoneet is a redox enzyme catalyzing electron transfer from fmnh2 to oxygen or ubiquinone","volume":"292","author":"Wang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113243_bb0255","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1073\/pnas.0701078104","article-title":"Mitoneet is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity","volume":"104","author":"Wiley","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2020.113243_bb0260","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/33423","article-title":"Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells","volume":"392","author":"Zambrowicz","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2020.113243_bb0265","doi-asserted-by":"crossref","first-page":"13047","DOI":"10.1073\/pnas.1109986108","article-title":"Facile transfer of [2fe-2s] clusters from the diabetes drug target mitoneet to an apo-acceptor protein","volume":"108","author":"Zuris","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620300741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620300741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:21:58Z","timestamp":1777407718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488620300741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":52,"alternative-id":["S0014488620300741"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113243","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioenergetic restoration and neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113243"}}